DR. LAL PATH LABS LTD. Valuation
LALPATHLAB · Healthcare · Current price ₹1,899.9
Is DR. LAL PATH LABS LTD. undervalued?
DocStoX estimates the fair value of DR. LAL PATH LABS LTD. at ₹1,006 per share, versus the current market price of ₹1,900. That puts the stock about -47.0% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹355), Relative P/E (₹1,949), Graham floor (₹319), Analyst target (₹1,959). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹319 (bear) to ₹1,006 (base) to ₹1,959 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
DR. LAL PATH LABS LTD. trades at a P/E of 63.1x and a P/B of 11.2x, with a dividend yield of 0.3%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on DR. LAL PATH LABS LTD.
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.